WVU Medicine Reynolds Memorial Hospital recently completed its first implant of the Altaviva device, developed by Medtronic, a new treatment option to ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults worldwide.

In November, the Food and Drug Administration (FDA) approved r-SNM, the first rechargeable sacral nerve stimulator cleared for full-body MRI scans, and sales results from the initial launch were ...

GLEN DALE, W.Va. — Reynolds Memorial Hospital has performed its first implantation of the Altaviva device, a new treatment option designed to help manage bladder control symptoms.Hospital officials ...

Dear Dr. Roach: My daughter, who is 50, recently went to a urologist for bladder retention issues. She had several tests performed. My daughter’s doctor told her that the diagnosis is “overactive ...

The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY, Ireland, Sept. 19, 2025 /PRNewswire ...

Sponsored FOY Tiny Device Provides Control and Confidence to Overactive Bladder Patients Raveen Syan, M.D., a urologist and Director of Female Pelvic Medicine and Urogynecology at the Desai Sethi ...

Bladder leakage is a problem for 60-percent of women. These kinds of incontinence issues can be a big problem, and significantly impact quality of life. Sarah Avrech is a mom of three. She started ...

Locating the nearest bathroom when she went shopping used to be as important for Kathy Boehm as finding items she was looking for. Bringing a change of clothes and adult diapers was a must-do when she ...

It's a problem nobody wants to talk about, suffering in silence and embarrassment. Of the 25 million Americans living with incontinence, 80% are women. But a pacemaker for the bladder may be the ...